Press Releases

Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate

Press Releases [...]

By |2022-09-15T13:06:49+00:00May 11th, 2021|Press Releases|Comments Off on Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate
Read More

Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy

Press Releases [...]

By |2022-09-15T13:05:40+00:00April 30th, 2021|Press Releases|Comments Off on Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy
Read More

National Bladder Awareness Month: A Look at the Facts about Pelvic Radiation Cancer Survivors

Press Releases [...]

By |2022-09-15T13:04:14+00:00November 12th, 2020|Press Releases|Comments Off on National Bladder Awareness Month: A Look at the Facts about Pelvic Radiation Cancer Survivors
Read More

Lipella Pharmaceuticals Initiates its Phase-2a Clinical Trial of LP-10 for Hemorrhagic Cystitis

Press Releases [...]

By |2022-09-15T13:02:38+00:00October 15th, 2020|Press Releases|Comments Off on Lipella Pharmaceuticals Initiates its Phase-2a Clinical Trial of LP-10 for Hemorrhagic Cystitis
Read More

Lipella Pharmaceuticals Inc. Code of Ethics

CHARTERS:

Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Charter

Lipella Pharmaceuticals Inc.
7800 Susquehanna St, Suite 505
Pittsburgh, PA 15208
USA

2023  © Copyright - Lipella Pharmaceuticals, Inc.

Go to Top